Carillon Tower Advisers’s HealthEquity HQY Stock Holding History

Carillon Tower Advisers’s Portfolio HQY Stock Details HQY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$5.71M	Sell	81,844 -4,000	-5%	-$249K	0.03%	399
2020 Q3	$4.41M	Sell	85,844 -212,694	-71%	-$11.7M	0.06%	348
2020 Q2	$17.5M	Buy	298,538 +21,098	+8%	+$1.17M	0.14%	212
2020 Q1	$12.6M	Sell	277,440 -188,807	-40%	-$12.5M	0.12%	238
2019 Q4	$34.5M	Sell	466,247 -2,500	-0.5%	-$156K	0.23%	153
2019 Q3	$26.8M	Buy	468,747 +76,706	+20%	+$5.09M	0.19%	197
2019 Q2	$25.6M	Sell	392,041 -67,531	-15%	-$4.7M	0.18%	210
2019 Q1	$34M	Sell	459,572 -292,910	-39%	-$20.6M	0.24%	155
2018 Q4	$44.9M	Hold	752,482	–	–	0.38%	79
2018 Q3	$71M	Hold	752,482	–	–	0.51%	48
2018 Q2	$56.5M	Buy	752,482 +664,157	+752%	+$47.7M	0.44%	66
2018 Q1	$53.5M	Sell	88,325 -642,486	-88%	-$34.8M	0.42%	67
2017 Q4	$34.1M	Buy	+730,811	New	+$36.2M	0.36%	99

Other funds holding HQY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

ESCM

Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return

Carillon Tower Advisers's HQY Position: Q4 2020 in Review

Carillon Tower Advisers reduced its HealthEquity (HQY) stake by 4.7% in Q4 2020, selling an estimated $249K and leaving 81,844 shares worth $5.71M. The position accounts for 0.03% of the portfolio, ranked #399.

Carillon Tower Advisers first reported a position in HQY in Q4 2017 and has held it in 13 quarters since. The position peaked at $71M in Q3 2018. 285 funds tracked by Wall St. Rank hold HQY as of Q4 2020.

Carillon Tower Advisers held 81,844 shares of HealthEquity worth $5.71M as of Q4 2020.
Carillon Tower Advisers sold 4,000 HealthEquity shares in Q4 2020, an estimated $249K.
HealthEquity made up 0.03% of Carillon Tower Advisers's portfolio in Q4 2020, its #399 holding.
Carillon Tower Advisers first reported a position in HealthEquity in Q4 2017 and has held it in 13 quarters since.
Carillon Tower Advisers's HealthEquity position peaked at $71M in Q3 2018.
285 funds tracked by Wall St. Rank held HealthEquity as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.